Induced Pluripotent Stem Cells Market Report

China Induced Pluripotent Stem Cells Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：208
  • REPORT CODE：GMM1821986
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Induced Pluripotent Stem Cells industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • System Biosciences

    • Stemgent

    • Cellular Dynamics

    • Reprocell

    • Fate Therapeutics

    • Cellectics

    • BrainStorm Cell Therapeutics Inc

    • CellTherapies P/L

    • Axiogenesis

    • Viacyte

    • Lonza

    • Iperian

    • Ocata Therapeutics Inc

    • Organogenesis Inc

    • Medipost Co Ltd

    By Type:

    • Others

    • Adult Sources

    • Fetal Sources

    By Application:

    • Autoimmune diseases

    • Hematopoietic stem cell transplantation

    • Tissue repair damage

    • As gene therapy vectors

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Induced Pluripotent Stem Cells Market Overview 2018-2029

    • 1.1 China Induced Pluripotent Stem Cells Industry Development Overview

    • 1.2 China Induced Pluripotent Stem Cells Industry Development History

    • 1.3 China Induced Pluripotent Stem Cells Industry Market Size (2018-2029)

    • 1.4 China Induced Pluripotent Stem Cells Market Analysis by Type from Production Side

      • 1.4.1 China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Adult Sources (2018-2029)

      • 1.4.3 China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Fetal Sources (2018-2029)

    • 1.5 China Induced Pluripotent Stem Cells Market Analysis by Application from Consumption End

      • 1.5.1 China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Autoimmune diseases (2018-2029)

      • 1.5.2 China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Hematopoietic stem cell transplantation (2018-2029)

      • 1.5.3 China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Tissue repair damage (2018-2029)

      • 1.5.4 China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of As gene therapy vectors (2018-2029)

    • 1.6 China Induced Pluripotent Stem Cells Market Analysis by Region

      • 1.6.1 North China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    Chapter 2 China Induced Pluripotent Stem Cells Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Induced Pluripotent Stem Cells Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Induced Pluripotent Stem Cells Market Status and Competition Analysis in 2023

      • 2.2.3 China Induced Pluripotent Stem Cells Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Induced Pluripotent Stem Cells Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Induced Pluripotent Stem Cells Industry Development

    Chapter 3 Induced Pluripotent Stem CellsIndustry Chain Analysis

    • 3.1 Induced Pluripotent Stem Cells Industry Chain

    • 3.2 Induced Pluripotent Stem Cells Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Induced Pluripotent Stem Cells Market

    • 3.3 Induced Pluripotent Stem Cells Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Induced Pluripotent Stem Cells Market

    Chapter 4 China Induced Pluripotent Stem Cells Market, by Type

    • 4.1 China Induced Pluripotent Stem Cells Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Induced Pluripotent Stem Cells Total Production Volume and Growth Rate from Production Side

    • 4.5 China Induced Pluripotent Stem Cells Production Volume and Growth Rate, by Type

      • 4.5.1 China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Others

      • 4.5.2 China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Adult Sources

      • 4.5.3 China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Fetal Sources

    Chapter 5 China Induced Pluripotent Stem Cells Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Induced Pluripotent Stem Cells Total Market Size and Growth Rate from Consumption End

    • 5.5 China Induced Pluripotent Stem Cells Market Size and Growth Rate, by Application

      • 5.5.1 China Induced Pluripotent Stem Cells Market Size and Growth Rate of Autoimmune diseases

      • 5.5.2 China Induced Pluripotent Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation

      • 5.5.3 China Induced Pluripotent Stem Cells Market Size and Growth Rate of Tissue repair damage

      • 5.5.4 China Induced Pluripotent Stem Cells Market Size and Growth Rate of As gene therapy vectors

    Chapter 6 China Induced Pluripotent Stem Cells Market, by Region

    • 6.1 China Induced Pluripotent Stem Cells Production Volume and Production Value, by Region

    • 6.2 China Induced Pluripotent Stem Cells Sales Volume and Sales Value, by Region

    Chapter 7 North China Induced Pluripotent Stem Cells Market Analysis

    • 7.1 North China Induced Pluripotent Stem Cells Market, by Type

    • 7.2 North China Induced Pluripotent Stem Cells Market, by Application

    Chapter 8 Central China Induced Pluripotent Stem Cells Market Analysis

    • 8.1 Central China Induced Pluripotent Stem Cells Market, by Type

    • 8.2 Central China Induced Pluripotent Stem Cells Market, by Application

    Chapter 9 South China Induced Pluripotent Stem Cells Market Analysis

    • 9.1 South China Induced Pluripotent Stem Cells Market, by Type

    • 9.2 South China Induced Pluripotent Stem Cells Market, by Application

    Chapter 10 East China Induced Pluripotent Stem Cells Market Analysis

    • 10.1 East China Induced Pluripotent Stem Cells Market, by Type

    • 10.2 East China Induced Pluripotent Stem Cells Market, by Application

    Chapter 11 Northeast China Induced Pluripotent Stem Cells Market Analysis

    • 11.1 Northeast China Induced Pluripotent Stem Cells Market, by Type

    • 11.2 Northeast China Induced Pluripotent Stem Cells Market, by Application

    Chapter 12 Southwest China Induced Pluripotent Stem Cells Market Analysis

    • 12.1 Southwest China Induced Pluripotent Stem Cells Market, by Type

    • 12.2 Southwest China Induced Pluripotent Stem Cells Market, by Application

    Chapter 13 Northwest China Induced Pluripotent Stem Cells Market Analysis

    • 13.1 Northwest China Induced Pluripotent Stem Cells Market, by Type

    • 13.2 Northwest China Induced Pluripotent Stem Cells Market, by Application

    Chapter 14 Company Profiles

      • 14.1 System Biosciences

        • 14.1.1 System Biosciences Company Profile

        • 14.1.2 System Biosciences Induced Pluripotent Stem Cells Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Stemgent

        • 14.2.1 Stemgent Company Profile

        • 14.2.2 Stemgent Induced Pluripotent Stem Cells Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Cellular Dynamics

        • 14.3.1 Cellular Dynamics Company Profile

        • 14.3.2 Cellular Dynamics Induced Pluripotent Stem Cells Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Reprocell

        • 14.4.1 Reprocell Company Profile

        • 14.4.2 Reprocell Induced Pluripotent Stem Cells Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Fate Therapeutics

        • 14.5.1 Fate Therapeutics Company Profile

        • 14.5.2 Fate Therapeutics Induced Pluripotent Stem Cells Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Cellectics

        • 14.6.1 Cellectics Company Profile

        • 14.6.2 Cellectics Induced Pluripotent Stem Cells Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BrainStorm Cell Therapeutics Inc

        • 14.7.1 BrainStorm Cell Therapeutics Inc Company Profile

        • 14.7.2 BrainStorm Cell Therapeutics Inc Induced Pluripotent Stem Cells Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 CellTherapies P/L

        • 14.8.1 CellTherapies P/L Company Profile

        • 14.8.2 CellTherapies P/L Induced Pluripotent Stem Cells Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Axiogenesis

        • 14.9.1 Axiogenesis Company Profile

        • 14.9.2 Axiogenesis Induced Pluripotent Stem Cells Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Viacyte

        • 14.10.1 Viacyte Company Profile

        • 14.10.2 Viacyte Induced Pluripotent Stem Cells Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Lonza

        • 14.11.1 Lonza Company Profile

        • 14.11.2 Lonza Induced Pluripotent Stem Cells Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Iperian

        • 14.12.1 Iperian Company Profile

        • 14.12.2 Iperian Induced Pluripotent Stem Cells Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Ocata Therapeutics Inc

        • 14.13.1 Ocata Therapeutics Inc Company Profile

        • 14.13.2 Ocata Therapeutics Inc Induced Pluripotent Stem Cells Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Organogenesis Inc

        • 14.14.1 Organogenesis Inc Company Profile

        • 14.14.2 Organogenesis Inc Induced Pluripotent Stem Cells Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Medipost Co Ltd

        • 14.15.1 Medipost Co Ltd Company Profile

        • 14.15.2 Medipost Co Ltd Induced Pluripotent Stem Cells Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Induced Pluripotent Stem Cells Industry Research Conclusions

    • 15.2 Induced Pluripotent Stem Cells Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Induced Pluripotent Stem Cells Industry Market Size (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Adult Sources (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Production Volume, Production Value and Growth Rate of Fetal Sources (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Autoimmune diseases (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Hematopoietic stem cell transplantation (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of Tissue repair damage (2018-2029)

    • Figure China Induced Pluripotent Stem Cells Sales Volume, Sales Value and Growth Rate of As gene therapy vectors (2018-2029)

    • Figure North China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Central China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure South China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure East China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Induced Pluripotent Stem Cells Market Size and Growth Rate from 2018-2029

    • Figure Induced Pluripotent Stem Cells Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Induced Pluripotent Stem Cells Market Share by Type in 2018

    • Figure China Induced Pluripotent Stem Cells Market Share by Type in 2023

    • Figure China Induced Pluripotent Stem Cells Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Adult Sources (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Production Volume and Growth Rate of Fetal Sources (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Market Share by Application in 2018

    • Figure China Induced Pluripotent Stem Cells Market Share by Application in 2023

    • Figure China Induced Pluripotent Stem Cells Total Market Size and Growth Rate from Consumption End

    • Figure China Induced Pluripotent Stem Cells Market Size and Growth Rate of Autoimmune diseases (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Market Size and Growth Rate of Hematopoietic stem cell transplantation (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Market Size and Growth Rate of Tissue repair damage (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Market Size and Growth Rate of As gene therapy vectors (2018-2023)

    • Table China Induced Pluripotent Stem Cells Production Volume by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Production Volume Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Production Volume Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Production Value by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Production Value Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Production Value Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Sales Volume by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Sales Volume Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Sales Volume Share by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Sales Value by Region (2018-2023)

    • Table China Induced Pluripotent Stem Cells Sales Value Share by Region (2018-2023)

    • Figure China Induced Pluripotent Stem Cells Sales Value Share by Region (2018-2023)

    • Table North China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table North China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure North China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table North China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table North China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure North China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Central China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table Central China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Central China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table South China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table South China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure South China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table South China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table South China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure South China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table East China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table East China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure East China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table East China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table East China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure East China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northeast China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table Northeast China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Southwest China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table Southwest China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells Production Volume by Type (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Figure Northwest China Induced Pluripotent Stem Cells Production Volume Share by Type (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells Sales Volume by Application (2018-2023)

    • Table Northwest China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Induced Pluripotent Stem Cells Sales Volume Share by Application (2018-2023)

    • Table System Biosciences Company Profile

    • Table System Biosciences Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Stemgent Company Profile

    • Table Stemgent Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Cellular Dynamics Company Profile

    • Table Cellular Dynamics Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Reprocell Company Profile

    • Table Reprocell Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Fate Therapeutics Company Profile

    • Table Fate Therapeutics Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Cellectics Company Profile

    • Table Cellectics Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table BrainStorm Cell Therapeutics Inc Company Profile

    • Table BrainStorm Cell Therapeutics Inc Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table CellTherapies P/L Company Profile

    • Table CellTherapies P/L Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Axiogenesis Company Profile

    • Table Axiogenesis Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Viacyte Company Profile

    • Table Viacyte Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Lonza Company Profile

    • Table Lonza Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Iperian Company Profile

    • Table Iperian Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Ocata Therapeutics Inc Company Profile

    • Table Ocata Therapeutics Inc Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Organogenesis Inc Company Profile

    • Table Organogenesis Inc Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)

    • Table Medipost Co Ltd Company Profile

    • Table Medipost Co Ltd Induced Pluripotent Stem Cells Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US